Fluticasone proprionate occurs as glucocorticoid often prescribed as coarse of action for asthma and allergic rhinitis. These are marketed by using a marque Flixotide® by Allen & Hanburys and Flovent® by GlaxoSmithKline.

A accurate mechanisms of glucocorticoid action around bronchial asthma come unknown. Inflammation is recognized as an crucial component in the pathogenesis of asthma attack. Glucocorticoids own been shown to inhibit multiple cell types (e.g., mastocyte, eosinophile, basophile, lymph cell, macrophages, & neutrophile) & intermediator even production or secretion (e.g., histamine, eicosanoids, leukotrienes, & cytokines) included in the wheezy response. These anti-anti-inflammatory drug actions of glucocorticoids might contribute to their efficaciousness around bronchial asthma. Occasionally, yet, a action on the cells affected takes many times. So, inhaled steroids are non utilized for quick relief of asthma attack, however instead when preventive & maintenance therapy.

Clinical trials
This list is Non complete & should Non become construed when trend lines for coarse of action decisions. Look at also [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?termClinical=fluticasone&precision=specificity&strategy=therapy&filters=&orig_db=PubMed&db=PubMed&cmd=Search&term=%28fluticasone%29+AND+%28randomized+controlled+trial%5BPublication+Type%5D+OR+%28randomized%5BTitle%2FAbstract%5D+AND+controlled%5BTitle%2FAbstract%5D+AND+trial%5BTitle%2FAbstract%5D%29%29 PubMed clinical manuscripts referring to fluticasone] Burge, P.S.; Calverley, P.M.; Jones, P.W.; Spencer, S.; Anderson, J.The.; & Maslen T.K. (2000). [http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=10807619 Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.] British Medical Journal 320 (7245), 1297-1303. PMID 10807619. Paggiaro, P.L.; Dahle, R.; Bakran, I personally.; Frith, L.; Hollingworth, K.; & Efthimiou, J. (1998). Multicentre randomized placebo-controlled test of inhaled fluticasone propionate inside patients by using chronic impeding pulmonic disease. A Lancet 351 (9105), 773-780. PMID 9519948.